The purpose of this project is to measure the uptake of a new type of Positron Emission Tomography (PET) scan (using Ga68-PSMA) in relapsed glioblastoma. We would also like to examine if standard and new x-ray techniques such as PET can be used to predict the behaviour of the cancer. This will allow us to understand if this type of scan gives a clearer image of the tumour when compared to standard scanning.
To be considered for this study you must meet the following criteria:
- you have histologically confirmed glioblastoma
- evidence of relapsed GBM as per a recent MRI
Your participation in this study will require you to attend on two days for PET scans. The scans will take approximately 90 minutes. A blood sample will be collected – approximately 30mls at baseline.
This study will help ensure the optimal targeting of anti-cancer treatment and imaging in the future.
Sign up to this clinical trial below.
Brunton Ave, Melbourne VIC 3004, Australia
- Newcastle (Oncology) - Newcastle